Day: February 21, 2022

Douglas Dynamics Reports Fourth Quarter and Full Year 2021 Results

Douglas Dynamics Reports Fourth Quarter and Full Year 2021 Results

Work Truck Attachments Delivered Strong Fourth Quarter and Full Year Performance Fourth Quarter 2021 Highlights: Produced Net Sales of $152.9 million & Net Income of $8.8 million Delivered Adjusted EBITDA of $19.9 million Board authorized $50 million share repurchase program Announced 1Q22 quarterly dividend increase to $0.29 per share MILWAUKEE, Feb. 21, 2022 (GLOBE NEWSWIRE) — Douglas Dynamics, Inc. (NYSE: PLOW), North America’s premier manufacturer and upfitter of work truck attachments and equipment, today announced financial results for the fourth quarter and full year ended December 31, 2021. “Our Work Truck Attachments segment produced a strong fourth quarter, which capped off a tremendous year for the segment,” noted Bob McCormick, President and CEO. “The supply chain and inflationary headwinds impacting many sectors...

Continue reading

Altus Midstream Announces Fourth-Quarter and Full-Year 2021 Results

Altus Midstream Announces Fourth-Quarter and Full-Year 2021 Results

HOUSTON, Feb. 21, 2022 (GLOBE NEWSWIRE) — Altus Midstream Company (Nasdaq: ALTM) today announced its fourth-quarter and full-year 2021 results. Results can be found on the company’s website at www.altusmidstream.com/investors. About Altus Midstream Company Altus Midstream Company is a pure-play, Permian-to-Gulf Coast midstream C-corporation. Through its consolidated subsidiaries, Altus owns gas gathering, processing and transmission assets servicing production in the Delaware Basin and owns equity interests in four Permian-to-Gulf Coast pipelines. Altus posts announcements, operational updates, investor information and press releases on its website, www.altusmidstream.com. Contacts Media: (713) 296-7276 Alexandra Franceschi Investor: (281) 302-2286 Patrick Cassidy                          

Continue reading

APA Corporation Announces Fourth-Quarter and Full-Year 2021 Financial and Operational Results

APA Corporation Announces Fourth-Quarter and Full-Year 2021 Financial and Operational Results

HOUSTON, Feb. 21, 2022 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today announced fourth-quarter and full-year 2021 results. Results can be found on the company’s website by visiting www.apacorp.com or investor.apacorp.com. There will be a conference call Feb. 22 at 10 a.m. Central time to discuss the results. It will be webcast and archived on APA’s website and available for playback by telephone for one week. The number for the replay is 855-859-2056 or 404-537-3406 for international calls. The conference access code is 7959588. About APA APA Corporation owns consolidated subsidiaries that explore for and produce oil and natural gas in the United States, Egypt and the United Kingdom and that explore for oil and natural gas offshore Suriname. APA posts announcements, operational updates, investor information and press releases...

Continue reading

Sun Communities, Inc. Reports 2021 Fourth Quarter Results and 2022 Guidance

Sun Communities, Inc. Reports 2021 Fourth Quarter Results and 2022 Guidance

Southfield, MI, Feb. 21, 2022 (GLOBE NEWSWIRE) — Sun Communities, Inc. (NYSE: SUI) (the “Company”), a real estate investment trust (“REIT”) that owns and operates, or has an interest in, manufactured housing (“MH”) communities, recreational vehicle (“RV”) resorts and marinas (collectively, the “properties”), today reported its fourth quarter results for 2021. Financial Results for the Quarter and Year Ended December 31, 2021 For the quarter ended December 31, 2021, total revenues increased by $158.2 million, or 41.2 percent, to $542.4 million compared to approximately $384.3 million for the same period in 2020. Net income attributable to common stockholders increased by $5.2 million, or 69.1 percent, to $12.8 million, or $0.11 per diluted common share, compared to net...

Continue reading

Harvard Bioscience Schedules Fourth Quarter 2021 Earnings Conference Call for March 8, 2022 at 8:00 AM ET

Harvard Bioscience Schedules Fourth Quarter 2021 Earnings Conference Call for March 8, 2022 at 8:00 AM ET

HOLLISTON, Mass., Feb. 21, 2022 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2021 before the market opens on March 8, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. You can access the live conference call by dialing the following phone numbers: toll-free 1 (877) 303-7611 or international 1 (970) 315-0445 and referencing the conference ID #1749525. The conference call will be simultaneously webcast and can be accessed through the Harvard Bioscience website. To listen to the webcast, go to http://investor.harvardbioscience.com/ – Events & Presentations. Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations...

Continue reading

Glatfelter Corporation to Present at the JP Morgan Global High Yield and Leveraged Finance Conference

Glatfelter Corporation to Present at the JP Morgan Global High Yield and Leveraged Finance Conference

CHARLOTTE, N.C., Feb. 21, 2022 (GLOBE NEWSWIRE) — Glatfelter Corporation (NYSE: GLT), a leading global supplier of engineered materials, today announced that Samuel L. Hillard, Senior Vice President and Chief Financial Officer and Ramesh Shettigar, Vice President, ESG, Investor Relations and Corporate Treasurer will be presenting at the JP Morgan Global High Yield and Leveraged Finance Conference on Monday, February 28, 2022. Glatfelter’s presentation will begin at 3:30 pm ET. In addition, Mr. Hillard and Mr. Shettigar will conduct one-on-one meetings with investors. A copy of the Company’s presentation will be available on Glatfelter’s Investors page on the morning of the presentation at Webcasts and Presentations – Glatfelter Engineered Materials. About Glatfelter Glatfelter is a leading global supplier of engineered materials...

Continue reading

<div>3D Systems & Saremco Dental AG Enter Strategic Partnership to Advance Digital Dentistry</div>

3D Systems & Saremco Dental AG Enter Strategic Partnership to Advance Digital Dentistry

Saremco CROWNTEC Material Employing CROWNTEC as part of the NextDent digital dentistry solution enables production of permanent crowns that are 30% stronger than those produced using previous generations of C&B materials while reducing material waste. Expanding distribution of Saremco’s industry-leading CROWNTEC™ material to U.S. for 3D printing permanent crowns with superior properties Producing permanent crowns with CROWNTEC & NextDent® 5100 digital dentistry solution 30% stronger than previous generation C&B resins Leveraging deep expertise of both organizations intended to accelerate R&D, time-to-market ROCK HILL, S.C. and REBSTEIN, Switzerland, Feb. 21, 2022 (GLOBE NEWSWIRE) — Today, 3D Systems (NYSE:DDD) and Saremco Dental AG announced a strategic partnership to accelerate innovation in digital dentistry....

Continue reading

Navios Maritime Holdings Inc. Announces the Date for the Release of Fourth Quarter and Year Ended 2021 Results, Conference Call and Webcast

Navios Maritime Holdings Inc. Announces the Date for the Release of Fourth Quarter and Year Ended 2021 Results, Conference Call and Webcast

Conference Call & Webcast: Thursday, February 24, 2022 at 8:30 am ET GRAND CAYMAN, Cayman Islands, Feb. 21, 2022 (GLOBE NEWSWIRE) — Navios Maritime Holdings Inc. (“Navios Holdings”) (NYSE:NM) announced today that it will host a conference call on Thursday, February 24, 2022 at 8:30 am ET, at which time Navios Holdings’ senior management will provide highlights and commentary on earnings results for the fourth quarter and year ended December 31, 2021. The Company will report results for the fourth quarter and year ended December 31, 2021, prior to the conference call. A supplemental slide presentation will be available on the Navios Holdings website at www.navios.com under the “Investors” section by 8:00 am ET on the day of the call. Conference Call details:Call Date/Time: Thursday, February 24,...

Continue reading

Sight Sciences to Participate in the Upcoming Citi Virtual Healthcare Conference

Sight Sciences to Participate in the Upcoming Citi Virtual Healthcare Conference

MENLO PARK, Calif., Feb. 21, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced plans to participate in the upcoming Citi Virtual Healthcare Conference. Sight Sciences’ management is scheduled to participate in a fireside chat February 23, 2022, at 8:45am PT. Interested parties may access a live and archived webcast of the fireside chat on the “Investors” section of the company’s website at: https://investors.sightsciences.com/. About Sight SciencesSight Sciences is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform standards of care and improve patients’ lives. Using minimally invasive or non-invasive...

Continue reading

Core One Labs’ Files Milestone Patent for Protection of its Recombinant Production System for Optimized Biosynthetic N-methyltryptamine (NMT)

Core One Labs’ Files Milestone Patent for Protection of its Recombinant Production System for Optimized Biosynthetic N-methyltryptamine (NMT)

VANCOUVER, British Columbia, Feb. 21, 2022 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Vocan Biotechnologies Inc. of Victoria, British Columbia, has filed a patent application with the United States Patent and Trademark Office (“USPTO”) for the production of biosynthetic N-methyltryptamine (NMT) (also known as monomethyl tryptamine (MMT)) through its optimized recombinant production system (the “System”). N-Methyltryptamine is a member of tryptamines and is an organic compound known to produce psychoactive effects when combined with a monoamine oxidase A inhibitor (MAOI).1 The patent entitled “Production of Psychedelic Compounds” protects Core One’s novel proprietary production system. The System,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.